Literature DB >> 19690152

Mechanistic study on hepatocarcinogenesis of piperonyl butoxide in mice.

Masaomi Kawai1, Yukie Saegusa, Meilan Jin, Yasuaki Dewa, Jihei Nishimura, Tomoaki Harada, Makoto Shibutani, Kunitoshi Mitsumori.   

Abstract

To clarify the mechanism of piperonyl butoxide (PBO)-induced hepatocarcinogenesis in mice, male mice were subjected to a two-thirds partial hepatectomy, N-diethylnitrosamine (DEN) initiation, and a diet containing 0.6% PBO for eight weeks. The incidence of gamma-glutamyl transpeptidase (GGT)-positive foci and PCNA-positive cells was significantly increased in the DEN + PBO group compared with the DEN-alone group. Real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis showed up-regulation of genes related to metabolism, such as cytochrome P450 1A1 and 2B10, and metabolic stress, such as Por, Nqo1, Nrf2, abcc3, and abcc4. Early responsive genes downstream of mitogen-activated protein kinase (MAPK), such as c-fos, c-jun, c-myc, and activating transcription factor 3 (ATF3), were also up-regulated in this group. Positive immunohistochemical staining for ATF3 was diffusely observed in nonproliferating hepatocytes of the DEN + PBO group, but altered foci were negative or weakly positive for ATF3. The nuclei of hepatocytes within ATF3-negative foci were positive for cyclin D. Thus PBO can induce oxidative stress, activate the MAPK pathway, and increase ATF3 transcript levels in hepatocytes outside the altered foci during the early stage of PBO-induced hepatocarcinogenesis in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690152     DOI: 10.1177/0192623309344087

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  3 in total

1.  Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase.

Authors:  Jephte Y Akakpo; Anup Ramachandran; Luqi Duan; Matthew A Schaich; Matthew W Jaeschke; Bret D Freudenthal; Wen-Xing Ding; Barry H Rumack; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

2.  ATF3 Demethylation Promotes the Transcription of ARL4C, Which Acts as a Tumor Suppressor in Human Breast Cancer.

Authors:  Liqi Li; Rong-Mao Sun; Guo-Qin Jiang
Journal:  Onco Targets Ther       Date:  2020-04-23       Impact factor: 4.147

3.  Expression and clinical significance of activating transcription factor 3 in human breast cancer.

Authors:  Hua Cao; Zhi-Xue Yang; Guo-Qin Jiang
Journal:  Iran J Basic Med Sci       Date:  2013-11       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.